Markets
China
China is one of the world’s largest and most dynamic markets, yet also one of the hardest for Western companies to navigate and enter. Silk Coast Ventures’ Nanjing and Hong Kong-based team specializes in connecting Western life science and healthcare innovators with lucrative, non-dilutive grant programs across China that emphasize entrepreneurship, foreign expertise, and international collaboration. These grants provide the upfront capital needed to establish a China strategy and local presence, creating a foundation to attract additional domestic investment and accelerate market entry.
In parallel, Silk Coast Ventures leverages established relationships with local strategics, development partners, and capital providers throughout the country to help companies scale sustainably and credibly within the Chinese ecosystem.
Southeast Asia
Singapore is the ideal launchpad for entering the broader Southeast Asian market, offering a trusted regulatory environment and strong healthcare infrastructure. Through ASEAN cooperation frameworks, companies that secure approval in Singapore can, in many cases, streamline access to other key markets such as Thailand, Malaysia, and Indonesia without repeating the most burdensome regulatory steps. From this base of clinical and regulatory validation, our team leverages deep relationships across the major ASEAN countries to help companies identify the right KOLs, strategic partners, and distribution networks needed to scale effectively across the region.